StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report released on Friday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
Navidea Biopharmaceuticals stock opened at $0.00 on Friday. Navidea Biopharmaceuticals has a one year low of $0.00 and a one year high of $0.15. The stock has a market capitalization of $100,084.00, a PE ratio of -0.02 and a beta of 1.47. The business’s fifty day moving average is $0.02 and its 200 day moving average is $0.04.
About Navidea Biopharmaceuticals
Featured Articles
- Five stocks we like better than Navidea Biopharmaceuticals
- With Risk Tolerance, One Size Does Not Fit All
- Survey: Top 175 Fittest Retirement Locations in America
- What is MarketRankā¢? How to Use it
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- Investing In Preferred Stock vs. Common Stock
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.